Marinus Pharma: Q1 Earnings Insights

Benzinga · 05/11/2023 07:10

Marinus Pharma (NASDAQ:MRNS) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM.

Here's what investors need to know about the announcement.


Marinus Pharma beat estimated earnings by 6.94%, reporting an EPS of $-0.67 versus an estimate of $-0.72.

Revenue was down $3.81 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 5.33% increase in the share price the next day.

Here's a look at Marinus Pharma's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.70 0.47 -0.68 -0.85
EPS Actual -0.76 -0.94 -1.06 -0.52
Revenue Estimate 5.35M 29.48M 2.31M 2.28M
Revenue Actual 7.16M 2.34M 1.79M 14.19M

To track all earnings releases for Marinus Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.